Evaluation of Patients (pts) with Neuroendocrine Tumors at First Cardiological Consultation with Echocardiographic (Echo) Method. Argentum Group

#1025

Introduction: The incidence of carcinoid tumors is approximately 1 in 75,000 of the population of whom 50% develop carcinoid syndrome. Once carcinoid syndrome has developed, approximately 50% of these patients develop carcinoid heart disease which typically causes abnormalities in the right side of the heart.

Aim(s): Assessed by Echo method and clinical factors, those pts with valvular and right ventricular involvement at the time of derivation to the Cardiooncologist Centralized Department for pts with metastatic neuroendocrine tumors.

Materials and methods: Study cohort, prospective, centralized in a single department evaluation of echocardiography in 48 patients with NETs, using the score of Echo, for the assessment of valvular damage as well as the function of the right ventricle. Patients with indication for surgery was determined at the time of referral.

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author: Santos D

Authors: Santos D, Pesce V, Bestanti C, O'Connor J, Marmissolle F,

Keywords: carcinoid, heart disease, 5-HIAA, neuroendocrine tumors,